Reflux treatments reduce risk of esophageal cancer

GERD affects 10% to 20% of adults in Western populations and has been known to be an increased risk factor for esophageal adenocarcinoma. Research on the association between antireflux medication or surgery and risk for esophageal adenocarcinoma has remained limited, although the typical approach has been to treat reflux aggressively when there are precancerous changes like

Robotic Surgery in Esophageal Cancer

Robot-assisted surgeries are becoming more commonplace, and having greater success. They have become state of the art for prostatic and pelvic surgeries and have a widespread recognition for being superior in the right hands. A recent randomized trial showed robotic laparoscopic esophagectomy led to significantly fewer complications while achieving similar cancer control, compared with open

Bacteria linked to esophageal cancer

Patients with higher levels of Tannerella forsythia bacteria, which can be associated with gum disease, may have a greater risk of esophageal cancer. The increase may be as much as 21% according to a study in Cancer Research. Other bacteria, for example Streptococcus and Neisseria bacteria, were linked to decreased risk. “Our study indicates that